503 related articles for article (PubMed ID: 28689168)
21. [HTLV-1: Recent topics in epidemiologic, basic and clinical research].
Yasunaga J; Matsuoka M
Uirusu; 2013; 63(2):165-74. PubMed ID: 25366051
[TBL] [Abstract][Full Text] [Related]
22. Quantitative in situ PCR assay of HTLV-1 infected cells in peripheral blood lymphocytes of patients with ATL, HAM/TSP and asymptomatic carriers.
Hashimoto K; Higuchi I; Osame M; Izumo S
J Neurol Sci; 1998 Jul; 159(1):67-72. PubMed ID: 9700706
[TBL] [Abstract][Full Text] [Related]
23. Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nagasaka M; Yamagishi M; Yagishita N; Araya N; Kobayashi S; Makiyama J; Kubokawa M; Yamauchi J; Hasegawa D; Coler-Reilly ALG; Tsutsumi S; Uemura Y; Arai A; Takata A; Inoue E; Hasegawa Y; Watanabe T; Suzuki Y; Uchimaru K; Sato T; Yamano Y
Proc Natl Acad Sci U S A; 2020 May; 117(21):11685-11691. PubMed ID: 32393644
[TBL] [Abstract][Full Text] [Related]
24. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic analysis of cerebrospinal fluid reveals concurrent development of ATL in the CNS of a HAM/TSP patient.
Takeda R; Ishigaki T; Ohno N; Yokoyama K; Kawamata T; Fukuyama T; Araya N; Yamano Y; Uchimaru K; Tojo A
Int J Hematol; 2020 Jun; 111(6):891-896. PubMed ID: 31930455
[TBL] [Abstract][Full Text] [Related]
26. Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease.
Furtado Mdos S; Andrade RG; Romanelli LC; Ribeiro MA; Ribas JG; Torres EB; Barbosa-Stancioli EF; Proietti AB; Martins ML
J Med Virol; 2012 Apr; 84(4):664-71. PubMed ID: 22337307
[TBL] [Abstract][Full Text] [Related]
27. Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease.
Araya N; Sato T; Yagishita N; Ando H; Utsunomiya A; Jacobson S; Yamano Y
Viruses; 2011 Sep; 3(9):1532-48. PubMed ID: 21994794
[TBL] [Abstract][Full Text] [Related]
28. Human T cell lymphotropic virus type I (HTLV-I) p12I is dispensable for HTLV-I transmission and maintenance of infection in vivo.
Furukawa Y; Usuku K; Izumo S; Osame M
AIDS Res Hum Retroviruses; 2004 Oct; 20(10):1092-9. PubMed ID: 15585100
[TBL] [Abstract][Full Text] [Related]
29. Human T-lymphotropic virus 1: recent knowledge about an ancient infection.
Verdonck K; González E; Van Dooren S; Vandamme AM; Vanham G; Gotuzzo E
Lancet Infect Dis; 2007 Apr; 7(4):266-81. PubMed ID: 17376384
[TBL] [Abstract][Full Text] [Related]
30. Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study.
Ono A; Mochizuki M; Yamaguchi K; Miyata N; Watanabe T
Br J Ophthalmol; 1995 Mar; 79(3):270-6. PubMed ID: 7703209
[TBL] [Abstract][Full Text] [Related]
31. Manifestations of the human T-cell lymphotropic virus type I infection in childhood and adolescence.
Bittencourt AL; Primo J; Oliveira MF
J Pediatr (Rio J); 2006; 82(6):411-20. PubMed ID: 17171202
[TBL] [Abstract][Full Text] [Related]
32. Tackling HTLV-1 infection in ophthalmology: a nationwide survey of ophthalmic care in an endemic country, Japan.
Kamoi K; Okayama A; Izumo S; Hamaguchi I; Uchimaru K; Tojo A; Watanabe T; Ohno-Matsui K
Br J Ophthalmol; 2020 Dec; 104(12):1647-1651. PubMed ID: 32152142
[TBL] [Abstract][Full Text] [Related]
33. Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in martinique (French West Indies).
Merle H; Cabre P; Olindo S; Merle S; Smadja D
Am J Ophthalmol; 2002 Aug; 134(2):190-5. PubMed ID: 12140025
[TBL] [Abstract][Full Text] [Related]
34. Nucleotide sequence analysis of human T-cell lymphotropic virus type I pX and LTR regions from patients with sicca syndrome.
Beby-Defaux A; Frugier F; Bourgoin A; Moynet D; Hajjar C; Sainte-Foie S; Guillemain B; Agius G
J Med Virol; 1999 Oct; 59(2):245-55. PubMed ID: 10459164
[TBL] [Abstract][Full Text] [Related]
35. HTLV-I seroprevalence in patients with undefined uveitis in central Japan.
Goto K; Saeki K; Kurita M; Iijima Y; Miyake A; Ohno S
Jpn J Ophthalmol; 1994; 38(2):175-7. PubMed ID: 7967209
[TBL] [Abstract][Full Text] [Related]
36. Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.
Morgan DJ; Caskey MF; Abbehusen C; Oliveira-Filho J; Araujo C; Porto AF; Santos SB; Orge GO; Joia MJ; Muniz AL; Siqueira I; Glesby MJ; Carvalho E
AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1499-504. PubMed ID: 18160007
[TBL] [Abstract][Full Text] [Related]
37. [HTLV-I and ocular disease].
Ohba N; Nakao K
Nippon Ganka Gakkai Zasshi; 1993 Apr; 97(4):433-40. PubMed ID: 8317363
[TBL] [Abstract][Full Text] [Related]
38. Global epidemiology of HTLV-I infection and associated diseases.
Proietti FA; Carneiro-Proietti AB; Catalan-Soares BC; Murphy EL
Oncogene; 2005 Sep; 24(39):6058-68. PubMed ID: 16155612
[TBL] [Abstract][Full Text] [Related]
39. Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls.
Silva MT; Mattos P; Alfano A; Araújo AQ
J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1085-9. PubMed ID: 12876239
[TBL] [Abstract][Full Text] [Related]
40. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
